問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of General Internal Medicine

Digestive System Department

更新時間:2023-09-19

陳彥年
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

13Cases

2022-08-01 - 2027-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2018-01-01 - 2027-12-31

Phase III

A Multicenter, Randomized, Double-Blind, Placebo-Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Ulcerative Colitis
  • Condition/Disease

    Ulcerative Colitis

  • Test Drug

    Risankizumab

Participate Sites
6Sites

Recruiting5Sites

Terminated1Sites

2018-09-01 - 2023-09-20

Phase II

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Crohn's Disease
  • Condition/Disease

    Moderate-to-Severe Crohn′s Disease

  • Test Drug

    BMS-986165

Participate Sites
5Sites

Not yet recruiting2Sites

Recruiting2Sites

1 2